Download PDF
Thromb Haemost 2002; 87(03): 538
DOI: 10.1055/s-0037-1613037
Letters to the Editor
Schattauer GmbH

Enoxaparin and Unfractionated Heparin in Acute Coronary Syndromes without ST-segment Elevation

Javier Borja
1   Pharmacia Spain, S. A., Medical Department, Crta. De Rubí, Barcelona, Spain
,
Pere Olivella
1   Pharmacia Spain, S. A., Medical Department, Crta. De Rubí, Barcelona, Spain
› Author Affiliations
Further Information

Publication History

Received 15 October 2001

Accepted 19 November 2001

Publication Date:
14 December 2017 (online)

Also available at
    Permissions and Reprints

 

 

  • References

  • 1 Salvioni A, Casilli F, Assanelli E, Grazi M, Marenci G, Guazzi MD. Comparison of enoxaparin and unfractionated heparin on thrombin generation in acute coronary syndromes without ST-segment elevation. Thromb Haemost 2001; 86: 991-4.
    Thieme ConnectPubMedSearch in Google Scholar
  • 2 Klein W, Buchwald A, Hillis SE, Monrad S, Sanz G, Turpie AGG, Van der Meer J, Olafson E, Undenland S, Ludwig K. for the FRIC investigators. Comparison of low-molecular-weight heparin with unfractionated heparin acutely and with placebo for 6 weeks in the management of unstable coronary artery disease. Fragmin in Unstable Coronary Artery Disease Study (FRIC). Circulation 1997; 97: 61-8.
    PubMedSearch in Google Scholar
  • 3 The FRAX.I.S. study Group. Comparison of two treatment durations (6 days and 14 days) of a low molecular weight heparin with a 6 day treatment of unfractionated heparin in the initial management of unstable angina or non-Q-wave myocardial infarction: FRAXIS (FRAXiparine in Ischaemic Syndrome). Eur Heart J 1999; 20: 1553-62.
    CrossrefPubMedSearch in Google Scholar
  • 4 Antman EM, Mc Cabe CH, Gurfinkel EP, Turpie AGG, Berning PJLM, Salein DF, Bayés Ade Luna, Fox K, Lablanche JM, Radley D, Premmereur J. for the TIMI 11 B Investigators. Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) 11 B Trial. Circulation 1999; 100: 1593-601.
    CrossrefPubMedSearch in Google Scholar
  • 5 Eikelboom JI, Anand SS, Malmberg K, Weitz JI, Ginsberg JS, Yusuf S. Unfractionated heparin and low-molecular-weight heparin in acute coronary syndromes without ST elevation: a meta-analysis. Lancet 2000; 355: 1936-42.
    CrossrefPubMedSearch in Google Scholar
  • 6 Cohen M, Demers C, Gurfinkel EP, Turpie AGG, Fromell GJ, Goodman S, Lamger A, Calif RM, Premmereur J, Bigonzi F. for the Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group. A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. N Engl J Med 1997; 337: 447-52.
    CrossrefPubMedSearch in Google Scholar
  • 7 Holdright D, Patel D, Cunningham D, Thomas R, Hubbard W, Hendry G, Sutton G. Comparison of the effect of heparin and aspirin versus aspirin alone on transient myocardial ischemia and in-hospital prognosis in patients with unstable angina. J Am Coll Cardiol 1994; 24: 39-45.
    CrossrefPubMedSearch in Google Scholar